Back
BioLineRx Ltd. 10K Form
Sell
22
BLRX
BioLineRx Ltd.
Last Price:
$3.26
Seasonality Move:
-3.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BLRX News And Ratings
See the #1 stock for the next 7 days that we like better than BLRX
BLRX Financial Statistics
Sales & Book Value
| Annual Sales: | $29.1M |
|---|---|
| Cash Flow: | $-2.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.49 |
| Price / Book: | 0.73 |
Profitability
| EPS (TTM): | -1.36560 |
|---|---|
| Net Income (TTM): | $-3.1M |
| Gross Margin: | $19M |
| Return on Equity: | -18.74% |
| Return on Assets: | -7.08% |
BioLineRx Ltd. Earnings Forecast
Key BioLineRx Ltd. Financial Ratios
-
The Gross Profit Margin over the past 17 years for BLRX is 65.33%.
-
The Selling, General & Administrative Expenses for BLRX have been equal to 103.41% of Gross Profit Margin.
-
The Research & Development expenses have been 30.12% of Revenue.
-
The Net Earning history of BLRX is -31.86% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 11 years.
BioLineRx Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BLRX |
| CUSIP: | 09071M |
| Website: | biolinerx.com |
Debt
| Debt-to-Equity Ratio: | 0.58 |
|---|---|
| Current Ratio: | 2.09 |
| Quick Ratio: | 1.84 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BLRX Technical Analysis vs Fundamental Analysis
Sell
22
BioLineRx Ltd. (BLRX)
is a Sell
Is BioLineRx Ltd. a Buy or a Sell?
-
BioLineRx Ltd. stock is rated a SellThe current BioLineRx Ltd. [BLRX] share price is $3.26. The Score for BLRX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.